This Profile in Personalized Medicine features Danielle Bush, CPhT, Nonsterile Training Supervisor at Town & Country Compounding in Ramsey, New Jersey. The pharmacy has been a proud PCCA member since 1985.

Both hair growth and anti-aging fall beneath the dermatology umbrella: hair is an appendage of the skin, while anti-aging is directly related to skin aesthetics and health. Dermatologists often refer patients to compounding pharmacies for personalized solutions to issues in these areas. In this article, we review specific hair growth solutions and preparations as well as anti-aging compounds.

Compounding pharmacists offer unique solutions tailored to meet specific patient needs and should have the opportunity to share these options appropriately in their communities. While promoting awareness of compounding services is vital, it’s important to thoughtfully approach how you market the services your pharmacy provides. Poorly executed marketing can attract regulatory and legal scrutiny. As such, it’s essential to understand that all marketing content, including publicly available materials, are subject to review by regulators and legal entities

A forthcoming documentary from the LDN Research Trust gives compounding pharmacists, physicians and prescribers an opportunity to learn about a group of complex and debilitating syndromes that affect one in six Americans — syndromes that occur in almost every part of the body, often accompany each other and collectively exacerbate the patient’s pain and other symptoms. This article briefly summarizes these syndromes and their overlapping symptoms and discusses how you can help educate providers in your community — as well as your staff and patients — about their effects, along with the potential use of low-dose naltrexone (LDN) in compounding preparations.

Running a pharmacy without a strategy is like navigating a stormy sea without a compass. As a pharmacy owner, you're often caught up in daily operations, reacting to the chaos of the days, weeks and months. Before you know it, the year has flown by and you're simply celebrating survival. This article explains how strategic planning benefits your practice, including tips to get started.

Bacterial vaginosis (BV) is the most common vaginal infection that affects women around the globe. In addition to its effects on total health, BV can significantly impact reproductive wellness. The condition is thought to originate from a decrease of Lactobacilli in the vagina, resulting in an imbalance in the natural vaginal microbiome.1 In the following article, we explore the pathogens associated with BV and challenges with commercial treatments, as well as compounding options and an innovative base that may potentially improve patient compliance.

Our Profiles in Personalized Medicine highlights PCCA USA’s and PCCA Canada’s 2024 award winners, including recipients of our inaugural Compounding Technician of the Year award. Join us in celebrating their work and dedication to patients and prescribers, as well as their tireless efforts to advocate for our profession.

Suspensions are pharmaceutical dosage forms consisting of insoluble active ingredients dispersed in a base vehicle. An ideal suspension should be uniform in content so each dose contains an equivalent amount of one or more — most likely one — active pharmaceutical ingredients (APIs). We briefly review oral suspensions and why content uniformity is vital in compounded preparations, as well as showcase the most studied oral suspension, in the following article.

The fundamental purpose of hospice is to help patients retain comfort, dignity and quality of life as they approach the end of life. During this stage, nausea and vomiting — either caused by medication side effects or from symptoms of a disease — are common. These and other side effects may lead to unnecessary stress and patient discomfort. In the following article, we review a commonly used topical gel that lessens nausea and vomiting, as well as the PCCA base vehicle that may enhance penetration of active pharmaceutical ingredients (APIs).

The numbers are in — forecasters predict 1.1 billion women worldwide will experience menopause in 2025. In the U.S., more than 1 million women reach menopause each year, and more than 75 percent of these women are employed during menopause transition years. Research conducted by the National Institute on Aging indicates menopausal hormone therapy (MHT) reduced the severity of menopause symptoms while elevating mood, sexual function, cardiovascular and brain health.